1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Dementia Care Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Dementia Care Market, by Care Type
8.1.1. Home-based Care
8.1.1.1. Market Revenue and Forecast
8.1.2. Adult Day Care
8.1.2.1. Market Revenue and Forecast
8.1.3. Assisted Living Facilities
8.1.3.1. Market Revenue and Forecast
8.1.4. Nursing Home Care
8.1.4.1. Market Revenue and Forecast
8.1.5. Memory Care Centers
8.1.5.1. Market Revenue and Forecast
9.1. Dementia Care Market, by Dementia Type
9.1.1. Alzheimer’s Disease
9.1.1.1. Market Revenue and Forecast
9.1.2. Vascular Dementia
9.1.2.1. Market Revenue and Forecast
9.1.3. Lewy Body Dementia
9.1.3.1. Market Revenue and Forecast
9.1.4. Frontotemporal Dementia
9.1.4.1. Market Revenue and Forecast
9.1.5. Mixed Dementia
9.1.5.1. Market Revenue and Forecast
10.1. Dementia Care Market, by Service Type
10.1.1. Medical Care Services
10.1.1.1. Market Revenue and Forecast
10.1.2. Cognitive Therapy Services
10.1.2.1. Market Revenue and Forecast
10.1.3. Rehabilitation Services
10.1.3.1. Market Revenue and Forecast
10.1.4. Palliative & Supportive Care
10.1.4.1. Market Revenue and Forecast
10.1.5. Remote Monitoring & Digital Care
10.1.5.1. Market Revenue and Forecast
11.1. Dementia Care Market, by End-Use
11.1.1. Hospitals
11.1.1.1. Market Revenue and Forecast
11.1.2. Specialty Neurology Clinics
11.1.2.1. Market Revenue and Forecast
11.1.3. Long-term Care Facilities
11.1.3.1. Market Revenue and Forecast
11.1.4. Homecare Settings
11.1.4.1. Market Revenue and Forecast
12.1. Dementia Care Market, by Therapy & Support
12.1.1. Pharmacological Care
12.1.1.1. Market Revenue and Forecast
12.1.2. Non-pharmacological Care
12.1.2.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Care Type
13.1.2. Market Revenue and Forecast, by Dementia Type
13.1.3. Market Revenue and Forecast, by Service Type
13.1.4. Market Revenue and Forecast, by End-Use
13.1.5. Market Revenue and Forecast, by Therapy & Support
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Care Type
13.1.6.2. Market Revenue and Forecast, by Dementia Type
13.1.6.3. Market Revenue and Forecast, by Service Type
13.1.6.4. Market Revenue and Forecast, by End-Use
13.1.6.5. Market Revenue and Forecast, by Therapy & Support
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Care Type
13.1.7.2. Market Revenue and Forecast, by Dementia Type
13.1.7.3. Market Revenue and Forecast, by Service Type
13.1.7.4. Market Revenue and Forecast, by End-Use
13.1.7.5. Market Revenue and Forecast, by Therapy & Support
13.2. Europe
13.2.1. Market Revenue and Forecast, by Care Type
13.2.2. Market Revenue and Forecast, by Dementia Type
13.2.3. Market Revenue and Forecast, by Service Type
13.2.4. Market Revenue and Forecast, by End-Use
13.2.5. Market Revenue and Forecast, by Therapy & Support
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Care Type
13.2.6.2. Market Revenue and Forecast, by Dementia Type
13.2.6.3. Market Revenue and Forecast, by Service Type
13.2.7. Market Revenue and Forecast, by End-Use
13.2.8. Market Revenue and Forecast, by Therapy & Support
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Care Type
13.2.9.2. Market Revenue and Forecast, by Dementia Type
13.2.9.3. Market Revenue and Forecast, by Service Type
13.2.10. Market Revenue and Forecast, by End-Use
13.2.11. Market Revenue and Forecast, by Therapy & Support
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Care Type
13.2.12.2. Market Revenue and Forecast, by Dementia Type
13.2.12.3. Market Revenue and Forecast, by Service Type
13.2.12.4. Market Revenue and Forecast, by End-Use
13.2.13. Market Revenue and Forecast, by Therapy & Support
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Care Type
13.2.14.2. Market Revenue and Forecast, by Dementia Type
13.2.14.3. Market Revenue and Forecast, by Service Type
13.2.14.4. Market Revenue and Forecast, by End-Use
13.2.15. Market Revenue and Forecast, by Therapy & Support
13.3. APAC
13.3.1. Market Revenue and Forecast, by Care Type
13.3.2. Market Revenue and Forecast, by Dementia Type
13.3.3. Market Revenue and Forecast, by Service Type
13.3.4. Market Revenue and Forecast, by End-Use
13.3.5. Market Revenue and Forecast, by Therapy & Support
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Care Type
13.3.6.2. Market Revenue and Forecast, by Dementia Type
13.3.6.3. Market Revenue and Forecast, by Service Type
13.3.6.4. Market Revenue and Forecast, by End-Use
13.3.7. Market Revenue and Forecast, by Therapy & Support
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Care Type
13.3.8.2. Market Revenue and Forecast, by Dementia Type
13.3.8.3. Market Revenue and Forecast, by Service Type
13.3.8.4. Market Revenue and Forecast, by End-Use
13.3.9. Market Revenue and Forecast, by Therapy & Support
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Care Type
13.3.10.2. Market Revenue and Forecast, by Dementia Type
13.3.10.3. Market Revenue and Forecast, by Service Type
13.3.10.4. Market Revenue and Forecast, by End-Use
13.3.10.5. Market Revenue and Forecast, by Therapy & Support
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Care Type
13.3.11.2. Market Revenue and Forecast, by Dementia Type
13.3.11.3. Market Revenue and Forecast, by Service Type
13.3.11.4. Market Revenue and Forecast, by End-Use
13.3.11.5. Market Revenue and Forecast, by Therapy & Support
13.4. MEA
13.4.1. Market Revenue and Forecast, by Care Type
13.4.2. Market Revenue and Forecast, by Dementia Type
13.4.3. Market Revenue and Forecast, by Service Type
13.4.4. Market Revenue and Forecast, by End-Use
13.4.5. Market Revenue and Forecast, by Therapy & Support
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Care Type
13.4.6.2. Market Revenue and Forecast, by Dementia Type
13.4.6.3. Market Revenue and Forecast, by Service Type
13.4.6.4. Market Revenue and Forecast, by End-Use
13.4.7. Market Revenue and Forecast, by Therapy & Support
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Care Type
13.4.8.2. Market Revenue and Forecast, by Dementia Type
13.4.8.3. Market Revenue and Forecast, by Service Type
13.4.8.4. Market Revenue and Forecast, by End-Use
13.4.9. Market Revenue and Forecast, by Therapy & Support
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Care Type
13.4.10.2. Market Revenue and Forecast, by Dementia Type
13.4.10.3. Market Revenue and Forecast, by Service Type
13.4.10.4. Market Revenue and Forecast, by End-Use
13.4.10.5. Market Revenue and Forecast, by Therapy & Support
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Care Type
13.4.11.2. Market Revenue and Forecast, by Dementia Type
13.4.11.3. Market Revenue and Forecast, by Service Type
13.4.11.4. Market Revenue and Forecast, by End-Use
13.4.11.5. Market Revenue and Forecast, by Therapy & Support
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Care Type
13.5.2. Market Revenue and Forecast, by Dementia Type
13.5.3. Market Revenue and Forecast, by Service Type
13.5.4. Market Revenue and Forecast, by End-Use
13.5.5. Market Revenue and Forecast, by Therapy & Support
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Care Type
13.5.6.2. Market Revenue and Forecast, by Dementia Type
13.5.6.3. Market Revenue and Forecast, by Service Type
13.5.6.4. Market Revenue and Forecast, by End-Use
13.5.7. Market Revenue and Forecast, by Therapy & Support
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Care Type
13.5.8.2. Market Revenue and Forecast, by Dementia Type
13.5.8.3. Market Revenue and Forecast, by Service Type
13.5.8.4. Market Revenue and Forecast, by End-Use
13.5.8.5. Market Revenue and Forecast, by Therapy & Support
14.1. Eli Lilly and Company
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Eisai
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Biogen
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Roche
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Novartis
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. AbbVie
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Otsuka Pharmaceutical
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. TauRx Pharmaceuticals
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. BioArctic
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Alzheon
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
